Indicadores financieros
- Market Capitalization 4.69 M
- Employee 7
- Founded 2004
- CEO N/A
- Website www.lexariabioscience.com
- Headquarter Nevada, United States
- FIGI BBG000JQHT18
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.09
Relación precio/flujo de caja
22.59
Tickers relacionados
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4833 | PCSA Processa Pharmaceuticals, Inc. - Common Stock | 1.67 USD | -5.65% | +15.97% | -14.36% | -24.94% | 4.66 M USD | ||
| 4839 | LIMN Liminatus Pharma, Inc. - Class A Common Stock | 3.35 USD | -4.83% | -13.44% | -4.29% | +150.00% | 4.50 M USD | ||
| 4850 | XTLB XTL Biopharmaceuticals Ltd - American Depositary Shares | 1.88 USD | -5.05% | -5.05% | -21.67% | +109.35% | 4.45 M USD | ||
| 4853 | NCNA NuCana plc - American Depositary Shares | 1.04 USD | -0.95% | -8.77% | -21.21% | -51.63% | 4.33 M USD |